Comment: Nivolumab-based treatment halts melanoma progression

Bookmark and Share
Published: 31 May 2015
Views: 1912
Dr Steven O'Day - Beverly Hills Cancer Center, Los Angeles, USA

Dr Steven O'Day talks to ecancertv at ASCO 2015 about the findings from a randomised phase III trial which indicate that initial therapy with nivolumab alone or in combination with ipilimumab is significantly more effective than ipilimumab alone.

Read the news article for more.

  • Categories: